# President Donald Trump bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs.

*biotech · news · 2026-05-18 · KFF Health News*

## Key points

- Donald Trump bought up to $680,000 of Eli Lilly stock as his administration advanced policies favoring the company.
- Several Trump stock purchases coincided with a new Medicare pilot offering GLP-1 drugs like Lilly's at $50 per month.
- White House initiatives steered Medicare reimbursement and FDA approvals benefiting Lilly's GLP-1 obesity drug business.
- Four of Trump's Lilly stock trades are listed as 'unsolicited,' but the disclosure's meaning is unclear.
- Lilly's market growth projections rely heavily on Medicare coverage for obesity drugs starting July 2026.

**Companies:** Eli Lilly, Microsoft, Nvidia, Boeing, Target, Chipotle, West Pharmaceutical Services
**Countries:** United States

[Read the full story on KFF Health News](https://kffhealthnews.org/health-industry/trump-stock-trades-eli-lilly-glp-1-weight-loss-drugs-invest-ethics-disclosures/)

---

Canonical: https://newsio.io/n/a1e6579f-0b7f-45d7-9eb4-7ddb6644ea3a/president-donald-trump-bought-as-much-as-680000-in-stock-of-eli-lilly-the-maker
Summarized by Newsio from KFF Health News. https://newsio.io/how-it-works